Anika Therapeutics buy Barrington Research
Start price
03.11.23
/
50%
€19.70
Target price
03.11.24
€26.08
Performance (%)
29.95%
Price
16.07.24
€25.20
Summary
This prediction is currently active. The prediction currently has a performance of 29.95%. This prediction currently runs until 03.11.24. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Anika Therapeutics | 5.882% | 5.882% |
iShares Core DAX® | 1.776% | 3.175% |
iShares Nasdaq 100 | -1.037% | 1.869% |
iShares Nikkei 225® | -0.335% | 3.857% |
iShares S&P 500 | 0.854% | 2.567% |
Comments by Barrington_Research for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $24.00 to $28.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Stopped prediction by Barrington_Research for Anika Therapeutics
Anika Therapeutics
Start price
Target price
Perf. (%)
€23.40
09.05.24
09.05.24
€34.32
09.05.25
09.05.25
7.69%
16.07.24
16.07.24
Anika Therapeutics
Start price
Target price
Perf. (%)
€20.60
03.01.24
03.01.24
€26.58
03.01.25
03.01.25
24.27%
16.07.24
16.07.24